- Co-Diagnostics (NASDAQ:CODX) skyrockets 46% following today's announcement on multiplex SNP genotyping.
- Shares are back above the $6 level where the IPO was priced last summer.
- Previously: Co-Diagnostics announces advancement of Co-Primers technology in multiplex SNP genotyping (June 5)
Co-Diagnostics +46% after genotyping breakthrough
Recommended For You
More Trending News
About CODX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CODX | - | - |
Co-Diagnostics, Inc. |